COVID‐19 did not delay time from referral to definitive management for head and neck cancer patients in a regional Victorian centre

• Published in: ANZ Journal of Surgery 2021-07, Vol.91 (7-8), p.1364-1368
• Main Authors: Tan, Hannah, Preston, Joel, Hunn, Samuel, Kwok, Matthew, Borschmann, Michael
• Format: Article
• Language: English
• Subjects: Cancer; COVID; COVID-19; Delay time; Electronic health records; Electronic medical records; Head & neck cancer; head and neck; Health services; otolaryngology; Pandemics; Patients; Public health; Quality assurance; regional; Special; Statistical analysis; surgical oncology; Telemedicine
• ISSN: 1445-1433; 1445-2197
• DOI: 10.1111/ans.17057

Background The COVID‐19 pandemic has had widespread impacts on health services, particularly regarding the provision of urgent elective surgical services. It has influenced the evaluation of surgical patients, patient willingness to consult with medical services, and the ability to provide timely care to these patients. The aim of this study is to assess the impact of the COVID‐19 pandemic on the time to definitive management for head and neck cancer in a regional setting. Methods A retrospective review was performed through the University Hospital Geelong Head and Neck Unit records and electronic medical records. Ethics approval for quality assurance was attained. The primary outcome was time from the first clinic appointment to commencement of definitive management. Statistical analysis was performed using Prism (version 8.0, GraphPad). Results A total of 127 patients were identified, 64 in the pre‐COVID and 63 in the post‐COVID period. In the post‐COVID period, more patients (14.3%) had their first clinic appointment with telehealth compared to the pre‐COVID period (1.6%). There was also no significant difference in time from referral to first clinic appointment or time from first clinic appointment to date of definitive treatment decision or multidisciplinary meeting. There was no significant difference in definitive treatment modality between groups. Conclusion Despite increased adoption of telemedicine and increased public health considerations, there was no increase in time to definitive treatment from the time of referral to a regional head and neck cancer service. Despite increased adoption of telemedicine and increased public health considerations, there was no increase in time to definitive treatment from the time of referral to a regional head and neck cancer service. However, in the post‐COVID group, more patients had locally advanced tumours (T3 or T4) compared to pre‐COVID.